Electromed, Inc. develops, manufactures, markets and sells innovative products that provide airway clearance therapy, including the SmartVest Airway Clearance System and related products, to patients with compromised pulmonary function with a commitment to excellence and compassionate service. The SmartVest System features a programmable air pulse generator, a therapy garment worn over the upper body and a connecting hose, which together provide safe, comfortable, and effective airway clearance therapy.
The SmartVest System generates HFCWO, also known as High-Frequency Chest Compression, a technique for airway clearance therapy. The garment repeatedly compresses and releases the upper body at frequencies from 5 to 20 cycles per second creating a “mini cough”. Each compression (or oscillation) produces pulsations that thin and loosen secretions from the surfaces of the lung airways, thins mucus stuck in the lungs and propels them toward the mouth where they can be removed by normal coughing or suction.
Type | Public | |
Founded | 1992 | |
HQ | New Prague, MN, US | Map |
Website | smartvest.com |
USD | |
---|---|
Revenue (Q2, 2021) | 9.5m |
Gross profit (Q2, 2021) | 7.5m |
Gross profit margin (Q2, 2021), % | 79.2% |
Net income (Q2, 2021) | 1.2m |
EBIT (Q2, 2021) | 1.6m |
Market capitalization (7-Apr-2021) | 87.0m |
Closing stock price (7-Apr-2021) | 10.1 |
Cash (31-Dec-2020) | 11.7m |
EV | 75.3m |
USD | Q1, 2012 | Q2, 2012 | Q3, 2012 | Q1, 2013 | Q2, 2013 | Q3, 2013 | Q1, 2014 | Q2, 2014 | Q3, 2014 | Q1, 2015 | Q2, 2015 | Q3, 2015 | Q1, 2016 | Q2, 2016 | Q3, 2016 | Q1, 2017 | Q2, 2017 | Q3, 2017 | Q1, 2018 | Q2, 2018 | Q3, 2018 | Q1, 2019 | Q2, 2019 | Q3, 2019 | Q1, 2020 | Q2, 2020 | Q3, 2020 | Q2, 2021 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 5.4m | 4.8m | 4.8m | 4.0m | 3.9m | 3.2m | 3.4m | 3.5m | 4.0m | 4.8m | 4.9m | 4.6m | 5.0m | 6.3m | 6.0m | 5.5m | 6.4m | 6.7m | 6.4m | 7.0m | 7.1m | 7.3m | 8.0m | 7.4m | 8.3m | 8.5m | 8.7m | 9.5m |
Cost of goods sold | 1.3m | 1.3m | 1.4m | 1.2m | 1.3m | 756.7k | 1.1m | 978.0k | 1.4m | 1.5m | 1.5m | 1.4m | 1.1m | 1.4m | 1.4m | 1.2m | 1.4m | 1.4m | 1.4m | 1.4m | 1.5m | 1.7m | 2.0m | 1.8m | 2.0m | 1.9m | 2.2m | 2.0m |
Gross profit | 4.1m | 3.5m | 3.4m | 2.8m | 2.5m | 2.4m | 2.4m | 2.5m | 2.5m | 3.3m | 3.4m | 3.2m | 3.9m | 4.9m | 4.6m | 4.3m | 4.9m | 5.3m | 4.9m | 5.6m | 5.6m | 5.5m | 6.1m | 5.6m | 6.3m | 6.7m | 6.6m | 7.5m |
Gross profit Margin, % | 75% | 73% | 71% | 70% | 65% | 76% | 69% | 72% | 64% | 69% | 70% | 69% | 77% | 78% | 77% | 78% | 77% | 80% | 77% | 80% | 79% | 76% | 76% | 75% | 76% | 78% | 75% | 79% |
USD | Q1, 2012 | Q2, 2012 | Q3, 2012 | Q1, 2013 | Q2, 2013 | Q3, 2013 | Q1, 2014 | Q2, 2014 | Q3, 2014 | Q1, 2015 | Q2, 2015 | Q3, 2015 | Q1, 2016 | Q2, 2016 | Q3, 2016 | Q1, 2017 | Q2, 2017 | Q3, 2017 | Q1, 2018 | Q2, 2018 | Q3, 2018 | Q1, 2019 | Q2, 2019 | Q3, 2019 | Q1, 2020 | Q2, 2020 | Q3, 2020 | Q2, 2021 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Cash | 2.9m | 1.7m | 1.4m | 1.5m | 1.0m | 505.0k | 1.1m | 1.2m | 772.4k | 2.3m | 2.5m | 2.9m | 3.8m | 4.5m | 4.9m | 3.8m | 4.8m | 5.4m | 5.8m | 6.8m | 7.1m | 7.7m | 7.2m | 7.5m | 8.0m | 9.2m | 9.9m | 11.7m |
Accounts Receivable | 10.4m | 10.7m | 11.1m | 10.4m | 9.7m | 9.2m | 8.0m | 7.0m | 6.5m | 6.4m | 6.6m | 6.4m | 6.5m | 6.9m | 7.3m | 8.0m | 8.3m | 8.9m | 9.6m | 9.7m | 10.1m | 11.5m | 11.9m | 12.3m | 12.7m | 12.7m | 13.3m | 15.4m |
Prepaid Expenses | 419.2k | 467.0k | 515.0k | 463.4k | 358.9k | 465.0k | 460.9k | 298.6k | 448.3k | 485.7k | 372.2k | 481.5k | 501.0k | 341.5k | 442.6k | 497.4k | 425.9k | 492.0k | 565.9k | 379.7k | 483.8k | 415.5k | 329.3k | 400.8k | 476.1k | 313.4k | 361.0k | 381.8k |
Inventories | 2.2m | 2.4m | 2.4m | 2.3m | 1.9m | 2.1m | 1.4m | 2.3m | 2.6m | 2.2m | 2.2m | 2.4m | 2.2m | 2.4m | 2.3m | 2.6m | 2.6m | 2.6m | 2.5m | 2.4m | 2.2m | 2.8m | 2.7m | 2.7m | 2.7m | 2.7m | 2.6m | 2.6m |
USD | FY, 2012 | FY, 2013 | FY, 2014 | FY, 2015 | FY, 2016 | FY, 2017 | FY, 2018 | FY, 2019 | FY, 2020 |
---|---|---|---|---|---|---|---|---|---|
Net Income | 186.6k | (1.3m) | (1.3m) | 1.1m | 2.2m | 2.2m | 1.9m | 2.0m | 4.2m |
Depreciation and Amortization | 408.6k | 459.8k | 695.5k | 736.2k | 738.7k | 755.1k | 790.0k | 925.2k | 738.2k |
Inventories | (536.5k) | 1.0m | (855.9k) | 163.4k | (347.6k) | (28.3k) | 234.6k | (106.2k) | (449.3k) |
Accounts Payable | (58.6k) | (77.8k) | (302.3k) | 384.0k | 873.8k | (337.5k) | 556.0k | (2.6k) | (472.6k) |
USD | Q1, 2012 |
---|---|
Debt/Equity | 0.1 x |
Debt/Assets | 0.1 x |
Financial Leverage | 1.4 x |
When was Electromed founded?
Electromed was founded in 1992.
Who are Electromed key executives?
Electromed's key executives are Kathleen Skarvan, Mike MacCourt and Kristine Owata.
How many employees does Electromed have?
Electromed has 119 employees.
What is Electromed revenue?
Latest Electromed annual revenue is $32.5 m.
What is Electromed revenue per employee?
Latest Electromed revenue per employee is $272.9 k.
Who are Electromed competitors?
Competitors of Electromed include Hill-Rom Holdings, TruHearing and Predictive Oncology.
Where is Electromed headquarters?
Electromed headquarters is located at 500 6th Ave NW, New Prague.
Where are Electromed offices?
Electromed has an office in New Prague.
How many offices does Electromed have?
Electromed has 1 office.
Receive alerts for 300+ data fields across thousands of companies